Searched for
BIOGEN IDEC
Shantha Biotechnics CEO Harish Iyer moves to Bill and Melinda Gates Foundation as Senior AdvisorIyer was brought into Shantha in 2011 from Biocon at a time when the vaccine unit was facing action from WHO for its pentavalent vaccines.- Biogen Idec gets DCGI nod for multiple sclerosis oral drugThe company has received approval for the first oral therapy drug Tecfidera for multiple sclerosis by DCGI, Biogen Idec Biotech India Pvt L...
- Pay for surgeries, costly treatment with EMIs soonGlobally, patient financing companies like Springstone and Medicard bear the cost of a patient's treatment including surgeries.
- Biogen to bring its global drug portfolio to IndiaUS-based Biogen Idec plans to roll out its entire range of medicines in the fast-growing, Rs 40,000-crore Indian retail drug market over th...
- US-based Merck to double workforce by year-endUS-based $25-billion Merck also plans to launch drugs targeted to Indian patients and introduce a competitive pricing pattern.
- Biogen for inlicensing deal with Indian cosUS-based biotech company Biogen Idec, is looking for partnerships across the pharma value chain, including in-licensing of new experimental...
- Big Pharma seeks biotech dose to spur growthVincent Aita of Kilkenny Capital Management says he picks biotechnology stocks on their potential as takeover targets.
Load More- Biogen to bring its global drug portfolio to India